Congenital heart disease is a leading cause of morbidity and mortality in children

Image

Congenital heart disease is a leading cause of morbidity and mortality in children. This study was conducted to see the disease pattern in children reported to a busy cardiac center in Bangladesh from across country. This is a single day hospital based observational study. All patients were examined clinically and with chest X-Ray. ECG was done where indicated. Final diagnosis was made using Echocardiography. All data were collected from Echocardiography laboratory at the end of that day. While compiling this report, a pattern was found among patients and since on that particular day, a lot of patients came from different parts of the country, representing the demographic of the whole country, the author decided to publish this experience.

Congenital heart disease (CHD) is defined as structural malformation of the heart or great vessels that is present at birth. Whatever may be the time of diagnosis CHD is the single most common malformation which constitute about 30% of the total. Congenital heart defect may occur as an isolated form or in combination with others. Some of the defects are simple and some are complex. Major congenital heart defects (MCHD) are those of the heart or great vessels which necessitate surgical on catheter intervention in first six months of life. Pediatric cardiology was started as a subspecialty in Bangladesh in 1998 and initially pediatricians and public were not aware about existence of such a harmful disease in our community. Later, all concerned were educated by continuous medical education. A study conducted in Combined Military Hospital, Dhaka showed an incidence of 25/1000 live births in our country. The Baltimore Washington infant study reported the rate as 4/1000 live births. Less incidence in western country is contributed by fetal screening of heart in early pregnancy and abortion of diseased fetus play thereafter. Maternal health and nutritional status are also better in developed countries. Many hospital-based studies are conducted in many regions of the world but study in South Asia is limited. In this study, regional experience was highlighted. This study has taken a cross section of patient for survey from a single day arrival in a tertiary care busy pediatric cardiac outpatient clinic of Bangladesh. All the patient who reported as a referred case to a pediatric cardiologist of a tertiary care hospital on a busy day, 6 March 2017, was selected randomly. All the cases were seen by the paediatric cardiologist after a healthcare assistant measured the body weight and oxygen saturation of the patients. The cardiovascular system of every patient was examined thoroughly, and a provisional diagnosis was made. Chest x-ray and electrocardiogram (ECG) were advised in some of the cases and Echocardiography was advised for all cases for anatomical diagnosis of new cases or follow up of previous diseases or postintervention and post-surgery follow up. Patients were documented in a non-invasive laboratory in database. Adults with chest pain who reported to the paediatric cardiologist were excluded from enrollment. s were performed in six (9.06%) cases. Other study also showed more interventions than surgery in current scenario . Reason is most interventions are now coming up with good outcome and guardians of children always prefer non operative procedures on their children. Management plan (VI) was decided as per requirement of specific disease of the patient. Most of the cases were placed in follow up as they were mainly neonates and infants and time was given for spontaneous cure for simple lesions. Medical management was offered to patient with heart failure, pulmonary hypertension, and associated chest infection cases. Cases who were cured from previous simple CHD were discharged from follow up. Surgery was offered in some critical and complex cases and interventions were offered in feasible cases.

Thanks & Regards
David Johns
Journal Coordinator
American Journal of Phytomedicine and Clinical Therapeutics
WhatsApp- +44-118-3150-749